Costunolide induces mitochondria-mediated apoptosis in human gastric adenocarcinoma BGC-823 cells.

Abstract

BACKGROUND:

Costunolide, a sesquiterpene lactone extracted from Radix Aucklandiae, has the activity against multiple cancers. However, the effect of costunolide on gastric cancer (GC) have remained to be ambiguous. In this study, we investigated the underlying mechanisms of apoptosis induced by costunolide in human gastric adenocarcinoma BGC-823 cells in vitro and in vivo.

METHODS:

The viability of BGC-823 cells was detected by MTT assay. The apoptosis and mitochondrial membrane potential (ΔΨm) of BGC-823 cells induced by costunolide were analyzed by flow cytometry. The inhibiton of costunolide on human gastric adenocarcinoma was estimated in xenografts in nude mice. Apoptosis related proteins and genes were detected by Western blot and Q-PCR.

RESULTS:

Costunolide inhibited the viability of BGC-823 cells in a time and concentration dependent manner. Costunolide induced the apoptosis and lowered the ΔΨm of BGC-823 cells significantly. Costunolide increased the expression of Bax, cleaved caspase 9, cleaved caspase 7, cleaved caspase 3 and cleaved poly ADP ribose polymerase (PARP) proteins and decreased the expression of Bcl-2, pro-caspase 9, pro-caspase 7, pro-caspase 3 and PARP proteins. Costunolide upregulated the expression of puma, Bak1 and Bax mRNA and downregulated the expression of Bcl-2 mRNA. In addition, we demonstrated that costunolide inhibited the growth and induced apoptosis of BGC-823 cells xenografted in athymic nude mice. Costunolide increased the expression of cleaved caspase 9, cleaved caspase 3 and Bax proteins and decreased the expression of Bcl-2 protein in xenografted tumor. Costunolide upregulated the expression of puma and Bax mRNA and decreased the expression of Bcl-2 mRNA in xenografted tumor.

CONCLUSIONS:

Collectively, our results suggested that costunolide induced mitochondria-mediated apoptosis in human gastric adenocarcinoma BGC-823 cells and could be the candidate drug against GC in clinical practice.

• Authors: Zhanpeng Yan, Tingting Xu, Zhentao An, Ying Hu, Wanzhen Chen, Jinxia Ma, Changle Shao, Fangshi Zhu
• Journal: BMC complementary and alternative medicine (BMC Complement Altern Med) Vol. 19 Issue 1 Pg. 151 (Jun 26 2019) ISSN: 1472-6882 [Electronic] England
• PMID: 31242894 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents, Phytogenic
• Proto-Oncogene Proteins c-bcl-2
• Sesquiterpenes
• costunolide
• Poly(ADP-ribose) Polymerases
• Caspases

Topics

• Adenocarcinoma (drug therapy, genetics, metabolism, physiopathology)
• Animals
• Antineoplastic Agents, Phytogenic (administration & dosage)
• Apoptosis (drug effects)
• Caspases (genetics, metabolism)
• Cell Line, Tumor
• Cell Proliferation (drug effects)
• Female
• Humans
• Mice
• Mice, Inbred BALB C
• Mice, Nude
• Mitochondria (drug effects, metabolism)
• Poly(ADP-ribose) Polymerases (genetics, metabolism)
• Proto-Oncogene Proteins c-bcl-2 (genetics, metabolism)
• Sesquiterpenes (administration & dosage)
• Stomach Neoplasms (drug therapy, genetics, metabolism, physiopathology)